Press Releases

All Releases
AngioDynamics Reports Fiscal 2016 Second Quarter Results
Jan 07, 2016
Net sales of $89.2 million GAAP loss of $0.01 per share; Non-GAAP adjusted EPS of $0.14 Operating cash generation of $9.6 million ALBANY, N.Y. , Jan. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access,
AngioDynamics to Present at the 34th Annual J.P. Morgan Global Healthcare Conference
Jan 04, 2016
ALBANY, N.Y. , Jan. 04, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph DeVivo , President and Chief Executive Officer, is
AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results
Dec 28, 2015
ALBANY, N.Y. , Dec. 28, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 second
FDA Lifts Warning Letters on AngioDynamics' Facilities
Dec 03, 2015

Completes Resolution of All Outstanding Warning Letters

AngioDynamics to Present at the Piper Jaffray 27th Annual Healthcare Conference
Nov 23, 2015
ALBANY, N.Y. , Nov. 23, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics Announces Resolution of FDA Warning Letter
Nov 17, 2015
ALBANY, N.Y. , Nov. 17, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announces that it has received a letter from the United Stated Food and Drug
AngioDynamics to Present at the 2015 Canaccord Genuity Medical Technology & Diagnostics Forum
Nov 11, 2015
ALBANY, N.Y. , Nov. 11, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics Announces Resignation of CFO and Appointment of Interim CFO
Nov 09, 2015
ALBANY, N.Y. , Nov. 09, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Mark Frost has resigned as Executive Vice President and
AngioDynamics Announces the Approval of the NanoKnife System in South Korea
Oct 15, 2015
ALBANY, N.Y. , Oct. 15, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that the NanoKnife® System has been approved by South
AngioDynamics Reports Fiscal 2016 First Quarter Results
Oct 08, 2015
Net sales of $83.7 million GAAP loss of $0.02 per share; Non-GAAP adjusted EPS of $0.11 Operating cash generation of $4.7 million Management provides Q2 outlook and reiterates FY2016 guidance ALBANY, N.Y. , Oct. 08, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of
AngioDynamics to Report Fiscal 2016 First Quarter Financial Results
Oct 01, 2015
ALBANY, N.Y. , Oct. 1, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 first
AngioDynamics to Present at the Morgan Stanley Global Healthcare Conference
Sep 02, 2015
ALBANY, N.Y. , Sept. 2, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Mark Frost , Executive Vice President and Chief Financial
Sawyer Fredericks, Local Crooner and Winner of Season Eight of "The Voice," to Perform at Third Annual St. Jude Gala Presented by AngioDynamics
Aug 18, 2015

<em>Fundraising Gala celebrating the life-saving efforts of the St. Jude Children's Research Hospital honors the Polish American Citizens Club of Albany</em>

Research Data Published in Annals of Surgery Concludes Irreversible Electroporation Utilizing NanoKnife Results in Substantially Prolonged Survival for Patients With Locally Advanced Pancreatic Cancer Compared With Historical Controls
Aug 13, 2015
ALBANY, N.Y. , Aug. 13, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the publication of clinical data from STAR (Soft Tissue Ablation
AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database
Aug 06, 2015
ALBANY, N.Y. , Aug. 6, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announce the enrollment of the first patient into the Registry of AngioVac
AngioDynamics to Present at the Canaccord Genuity 35th Annual Growth Conference
Aug 04, 2015
ALBANY, N.Y. , Aug. 4, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer, is
AngioDynamics Begins Shipment of New Midline Catheters
Aug 04, 2015

The New Product Category Launch is the Fourth Vascular Access Product Line to Include the Proprietary BioFlo Thromboresistant Material

AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
Jul 16, 2015
Fourth quarter fiscal 2015 net sales of $90.9 million ; Full year net sales of $357 million Fourth quarter fiscal 2015 GAAP loss of $0.02 per share; Non-GAAP adjusted net income of $0.14 per share; full year non-GAAP adjusted income of $0.58 per share Fourth quarter fiscal 2015 operating cash
AngioDynamics to Report Fiscal 2015 Fourth Quarter and Full Year Financial Results
Jul 02, 2015
ALBANY, N.Y. , July 2, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 fourth
AngioDynamics to Present at the Jefferies 2015 Healthcare Conference
May 26, 2015
ALBANY, N.Y. , May 26, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Mark Frost , Executive Vice President and Chief Financial
Displaying 61 - 80 of 623

Copyright West LLC. Minimum 15 minutes delayed.